Skip to main content
Clinical Trials/CTRI/2026/01/101352
CTRI/2026/01/101352
Not yet recruiting
Not Applicable

TO ASSESS THE EFFICACY OF PARAVERTEBRAL BLOCK AND INTERCOSTAL NERVE BLOCK FOR THORACIC HERPES ZOSTER : RANDOMIZED COMPARATIVE STUDY

NIDHI CHINCHOLI1 site in 1 country40 target enrollmentStarted: January 21, 2026Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
NIDHI CHINCHOLI
Enrollment
40
Locations
1
Primary Endpoint
decrease in NRS score post block for herpes zoster

Overview

Brief Summary

Study design & technique : Randomized Comparative  Prospective study

Study duration : 18 months****Study design & technique : Randomized Comparative  Prospective study

40  patients aged  greater than 40 years of age of either gender  with herpes zoster greater than 1 week since onset of rash, involving up to 2 thoracic dermatomes with Numerical rating score (NRS) greater than 4 who shall visit the pain clinic and fulfill the inclusion and exclusion criteria will be included . After taking their due consent ,patients will be randomized into 2 groups with 20  in each group using sealed opaque envelope techniquey duration : 18 months

Both the blocks will be performed under ultrasound guidance using a high frequency linear probe following  strict aseptic precautions and using standard American Society of Anesthesiology  monitoring

Group I – INTERCOSTAL NERVE BLOCK    2.5  mL bupivacaine 0.25% + 2 mg dexamethasone is injected for each level .

Group P :PARAVERTEBRAL BLOCK 15 ml of 0.25% Bupivacaine with 8 mg of Dexamethasone will be injected for   into the thoracic paravertebral space .

Follow up:  Pre procedure, immediate post procedure and at intervals of 2, 4, 12 and 24 weeks   NRS,S - LANSS , SF 36 , complictions (if any ) and the  incidence of  Post herpetic neuralgia will be assessed

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant and Investigator Blinded

Eligibility Criteria

Ages
40.00 Year(s) to 90.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Age greater 40 years of age of either gender Herpes zoster greater 1 week since onset of rash HZ involving up to 2 thoracic dermatomes Numerical rating score (NRS)greater 4 Pain refractory to conservative management.

Exclusion Criteria

  • Infection at site of injection Patients with coagulopathy or on anticoagulants Patients on chemotherapy or immunosuppressive drugs Any contraindication to neuraxial injection Uncontrolled medical illness Hypersensitivity to LA Pregnancy and lactating women.

Outcomes

Primary Outcomes

decrease in NRS score post block for herpes zoster

Time Frame: decrease in pain NRS score post block for thoracic herpes zoster

Secondary Outcomes

  • decrease in incidence of PHN(6 months)

Investigators

Sponsor
NIDHI CHINCHOLI
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Nidhi Chincholi

JSS MEDICAL COLLEGE , mysore

Study Sites (1)

Loading locations...

Similar Trials